Radiofrequency Ablation for Hepatocellular Carcinoma.
- Author:
Se Young JANG
1
;
Soo Young PARK
Author Information
1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea. psyoung0419@gmail.com
- Publication Type:Review
- Keywords:
Ablation;
Hepatocellular carcinoma;
Ultrasonography
- MeSH:
Carcinoma, Hepatocellular*;
Catheter Ablation*;
Ultrasonography
- From:Journal of Liver Cancer
2015;15(2):79-83
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Radiofrequency ablation (RFA) takes an important role in management of hepatocellular carcinoma (HCC) as the most popular local therapy in the world. There are many data supporting that RFA is an excellent treatment modality for early-stage HCC with favorable treatment outcomes and minimal invasiveness. Currently, RFA extends treatement indications from unresectable early-stage HCC to intermediate-stage HCC in selected cases. Thus, with technical advances in guidance and ablation as well as devices, RFA widens its territory in the combat field against HCC.
